US
State Street SPDR S&P Biotech ETF
XBI · Equity
$135
+0.12%
Assets
n/a
Expense ratio
0.35%
Holdings
155
1Y return
+77.3%
Forward P/E
n/a
Top 10 holdings
+14.9%
Return and risk
| 1Y total return | +77.3% |
| 3Y total return | +57.7% |
| 5Y total return | +8.4% |
| 3Y CAGR | +16.4% |
| 5Y CAGR | +1.6% |
| Beta | 0.85 |
| RSI | 55.34 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 155 |
| Expense ratio | 0.35% |
| Dividend yield | +0.3% |
| Top 10 holdings | +14.9% |
| Volume | 6M |
All ETF indicators
| All Time High | 174.79 |
| All Time High Change | -22.82 |
| All Time High Date | 2021-02-09 |
| All Time Low | 13.92 |
| All Time Low Change | 868.97 |
| All Time Low Date | 2006-05-24 |
| Atr | 3.46 |
| Beta | 0.85 |
| Cagr10y | 10.46 |
| Cagr15y | 12.35 |
| Cagr1y | 77.33 |
| Cagr20y | 11.79 |
| Cagr3y | 16.39 |
| Cagr5y | 1.63 |
| Ch10y | 166.57 |
| Ch15y | 452.3 |
| Ch1m | 4.23 |
| Ch1w | 0.84 |
| Ch1y | 76.61 |
| Ch20y | 779.29 |
| Ch3m | 8.23 |
| Ch3y | 56.85 |
| Ch5y | 7.84 |
| Ch6m | 18.33 |
| Ch YTD | 10.65 |
| Close | 134.75 |
| Div CAGR10 | 0.44 |
| Div CAGR3 | 454.12 |
| Div CAGR5 | 9.61 |
| Dividend Growth | 235.92 |
| Dividend Growth Years | 2 |
| Dividend Years | 3 |
| Dividend Yield | 0.33 |
| Dps | 0.44 |
| Ex Div Date | 2025-12-22 |
| High52 | 139.19 |
| High52ch | -3.07 |
| High52 Date | 2026-04-17 |
| Inception Date | 2006-01-31 |
| Isin | US78464A8707 |
| Last Dividend | 0.41 |
| Low52 | 75.71 |
| Low52ch | 78.19 |
| Low52 Date | 2025-05-15 |
| Ma150 | 122.7 |
| Ma150ch | 9.95 |
| Ma20 | 134.39 |
| Ma200 | 115.12 |
| Ma200ch | 17.19 |
| Ma20ch | 0.39 |
| Ma50 | 129.06 |
| Ma50ch | 4.54 |
| Payment Date | 2025-12-24 |
| Price Date | 2026-05-12 |
| Rsi | 55.34 |
| Rsi Monthly | 73.75 |
| Rsi Weekly | 64.4 |
| Sharpe Ratio | 2.24 |
| Sortino Ratio | 4.08 |
| Top10holdings | 14.88 |
| Tr10y | 170.39 |
| Tr15y | 473.31 |
| Tr1m | 4.23 |
| Tr1y | 77.26 |
| Tr20y | 828.99 |
| Tr3m | 8.23 |
| Tr3y | 57.69 |
| Tr5y | 8.42 |
| Tr6m | 18.72 |
| Tr YTD | 10.65 |